Aemetis Inc (AMTX) Stock Rating Upgraded by Zacks Investment Research

Zacks Investment Research upgraded shares of Aemetis Inc (NASDAQ:AMTX) from a sell rating to a hold rating in a research report report published on Thursday, July 20th.

According to Zacks, “Aemetis, Inc. is an advanced fuels and renewable chemicals company. It produces renewable chemicals and fuels using patented microbes and processes. Aemetis owns and operates an ethanol animal feed plant in California to produce D5 Advanced Biofuels using the sorghum/biogas/CHP pathway. The Company also built, owns, and operates a renewable chemicals and advanced fuels production facility on the East Coast of India producing high quality, distilled biodiesel and refined glycerin for customers in Europe and Asia. Aemetis, Inc. is headquartered in Cupertino, California. “

Separately, FBR & Co set a $2.00 price target on shares of Aemetis and gave the stock a hold rating in a report on Tuesday, May 16th.

Aemetis (AMTX) traded up 0.8120% during trading on Thursday, reaching $1.1795. The company’s stock had a trading volume of 24,143 shares. The company’s 50 day moving average price is $1.30 and its 200 day moving average price is $1.32. The company’s market cap is $23.23 million. Aemetis has a 52 week low of $1.01 and a 52 week high of $2.50.

TRADEMARK VIOLATION WARNING: This story was published by [[site]] and is owned by of [[site]]. If you are reading this story on another domain, it was illegally copied and republished in violation of United States & international trademark and copyright legislation. The correct version of this story can be accessed at [[permalink]].

An institutional investor recently raised its position in Aemetis stock. Geneva Advisors LLC increased its stake in Aemetis Inc (NASDAQ:AMTX) by 2.2% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,511,631 shares of the specialty chemicals company’s stock after buying an additional 32,400 shares during the period. Geneva Advisors LLC owned approximately 7.67% of Aemetis worth $1,950,000 at the end of the most recent quarter. 18.48% of the stock is currently owned by hedge funds and other institutional investors.

Aemetis Company Profile

Aemetis, Inc is an international renewable fuels and biochemicals company. The Company is focused on the production of fuels and chemicals through the acquisition, development and commercialization of technologies that replace traditional petroleum-based products by conversion of first-generation ethanol and biodiesel plants into biorefineries.

Get a free copy of the Zacks research report on Aemetis (AMTX)

For more information about research offerings from Zacks Investment Research, visit Zacks.com